Pamela Hamill PhD

Joined Merck in 2011 to support the development of clients’ cell-based and potency assay projects. Hamill now provides scientific and regulatory advice for customers on solutions for comprehensive virus safety testing and product characterization for biologics. Hamill previously held roles managing a diagnostic laboratory at the Canadian Food Inspection Agency and as an academic researcher, focusing on innate immune responses to infection and assays used to screen for anti-viral therapeutic candidates. Pamela received her PhD in virology from the University of Glasgow.